MicroRNA-141 regulates BMI1 expression and induces senescence in human diploid fibroblasts

Cell Cycle

Volumn 12, Issue 22, 2013, Pages 3537-3546

  Dimri, Manjari ^a   Carroll, Jeremy D ^a   Cho, Joon Ho ^a   Dimri, Goberdhan P ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aging; BMI1; microRNA; miR 141; Polycomb group proteins; Senescence

Indexed keywords

BMI1 PROTEIN; MESSENGER RNA; MICRORNA 141;

3' UNTRANSLATED REGION; ARTICLE; CELL AGING; CONTROLLED STUDY; DIPLOIDY; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; POSTTRANSCRIPTIONAL GENE SILENCING; RNA SEQUENCE; UPREGULATION;

AGING; BMI1; MICRORNA; MIR-141; POLYCOMB GROUP PROTEINS; SENESCENCE;

CELL AGING; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DIPLOIDY; DOWN-REGULATION; FIBROBLASTS; HUMANS; MICRORNAS; POLYCOMB REPRESSIVE COMPLEX 1; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84890353344     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.26592     Document Type: Article

References (59)

1. Sparmann A, van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 2006; 6:846-56; PMID:17060944; http://dx.doi.org/10.1038/nrc1991 (Pubitemid 44629896)
2. Richly H, Aloia L, Di Croce L. Roles of the Polycomb group proteins in stem cells and cancer. Cell Death Dis 2011; 2:e204; PMID:21881606; http://dx.doi. org/10.1038/cddis.2011.84
3. Valk-Lingbeek ME, Bruggeman SW, van Lohuizen M. Stem cells and cancer; the polycomb connection. Cell 2004; 118:409-18; PMID:15315754; http://dx.doi.org/10.1016/j.cell.2004.08.005 (Pubitemid 39485661)
4. Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 2005; 115:1503-21; PMID:15931389; http://dx.doi.org/10.1172/JCI23412 (Pubitemid 40814659)
5. Guo WJ, Zeng MS, Yadav A, Song LB, Guo BH, Band V, Dimri GP. Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells. Cancer Res 2007; 67:5083-9; PMID:17545584; http://dx.doi. org/10.1158/0008-5472.CAN-06-4368 (Pubitemid 46997242)
6. Kim JH, Yoon SY, Jeong SH, Kim SY, Moon SK, Joo JH, Lee Y, Choe IS, Kim JW. Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast 2004; 13:383-8; PMID:15454193; http://dx.doi.org/10.1016/j.breast.2004.02.010 (Pubitemid 39549787)
7. Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003; 423:255-60; PMID:12714970; http://dx.doi.org/10.1038/nature01572 (Pubitemid 40852690)
8. Leung C, Lingbeek M, Shakhova O, Liu J, Tanger E, Saremaslani P, Van Lohuizen M, Marino S. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 2004; 428:337-41; PMID:15029199; http://dx.doi. org/10.1038/nature02385 (Pubitemid 38418806)
9. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P, Wicha MS. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006; 66:6063-71; PMID:16778178; http://dx.doi. org/10.1158/0008-5472.CAN-06-0054
10. Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 2005; 19:1432-7; PMID:15964994; http://dx.doi.org/10.1101/gad.1299505 (Pubitemid 41003009)
11. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003; 425:962-7; PMID:14574365; http://dx.doi.org/10.1038/ nature02060 (Pubitemid 37376927)
12. Sangiorgi E, Capecchi MR. Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet 2008; 40:915-20; PMID:18536716; http://dx.doi.org/10.1038/ng. 165 (Pubitemid 351913652)
13. Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007; 23:675-99; PMID:17645413; http://dx.doi. org/10.1146/annurev.cellbio.22.010305.104154
14. Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009; 138:592-603; PMID:19665978; http://dx.doi. org/10.1016/j.cell.2009.07.011
15. Moon JH, Heo JS, Kim JS, Jun EK, Lee JH, Kim A, Kim J, Whang KY, Kang YK, Yeo S, et al. Reprogramming fibroblasts into induced pluripotent stem cells with Bmi1. Cell Res 2011; 21:1305-15; PMID:21709693; http://dx.doi.org/10.1038/ cr.2011.107
16. Onder TT, Kara N, Cherry A, Sinha AU, Zhu N, Bernt KM, Cahan P, Marcarci BO, Unternaehrer J, Gupta PB, et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature 2012; 483:598-602; PMID:22388813; http://dx.doi. org/10.1038/nature10953
17. Dimri GP. The search for biomarkers of aging: next stop INK4a/ARF locus. Sci Aging Knowledge Environ 2004; 2004:pe40; PMID:15525836; http://dx.doi.org/ 10.1126/sageke.2004.44.pe40
18. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011; 479:232-6; PMID:22048312; http://dx.doi. org/10.1038/nature10600
19. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, Beekman C, Theilgaard-Monch K, Minucci S, Porse BT, Marine JC, et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 2007; 21:525-30; PMID:17344414; http://dx.doi.org/10.1101/gad.415507 (Pubitemid 46409467)
20. Itahana K, Zou Y, Itahana Y, Martinez JL, Beausejour C, Jacobs JJ, Van Lohuizen M, Band V, Campisi J, Dimri GP. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol 2003; 23:389-401; PMID:12482990; http://dx.doi.org/10.1128/MCB.23.1.389-401.2003 (Pubitemid 36008529)
21. Chatoo W, Abdouh M, David J, Champagne MP, Ferreira J, Rodier F, Bernier G. The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity. J Neurosci 2009; 29:529-42; PMID:19144853; http://dx.doi. org/10.1523/JNEUROSCI.5303-08.2009
22. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999; 397:164-8; PMID:9923679; http://dx.doi.org/10.1038/16476 (Pubitemid 29050921)
23. Tschen SI, Dhawan S, Gurlo T, Bhushan A. Agedependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice. Diabetes 2009; 58:1312-20; PMID:19228811; http://dx.doi.org/10.2337/db08- 1651
24. Bommi PV, Dimri M, Sahasrabuddhe AA, Khandekar J, Dimri GP. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors. Cell Cycle 2010; 9:2663-73; PMID:20543557; http://dx.doi. org/10.4161/cc.9.13.12147
25. Datta S, Hoenerhoff MJ, Bommi P, Sainger R, Guo WJ, Dimri M, Band H, Band V, Green JE, Dimri GP. Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways. Cancer Res 2007; 67:10286-95; PMID:17974970; http://dx.doi. org/10.1158/0008- 5472.CAN-07-1636 (Pubitemid 350070802)
26. Kim RH, Lieberman MB, Lee R, Shin KH, Mehrazarin S, Oh JE, Park NH, Kang MK. Bmi-1 extends the life span of normal human oral keratinocytes by inhibiting the TGF-beta signaling. Exp Cell Res 2010; 316:2600-8; PMID:20630502; http://dx.doi.org/10.1016/j.yexcr.2010.04.013
27. Gargiulo G, Cesaroni M, Serresi M, de Vries N, Hulsman D, Bruggeman SW, Lancini C, van Lohuizen M. In vivo RNAi screen for BMI1 targets identifies TGF-β/BMP-ER stress pathways as key regulators of neural-and malignant gliomastem cell homeostasis. Cancer Cell 2013; 23:660-76; PMID:23680149; http://dx.doi.org/10.1016/j. ccr.2013.03.030
28. Cho JH, Dimri M, Dimri GP. A positive feedback loop regulates the expression of polycomb group protein BMI1 via WNT signaling pathway. J Biol Chem 2013; 288:3406-18; PMID:23239878; http://dx.doi. org/10.1074/jbc.M112.422931
29. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-97; PMID:14744438; http://dx.doi.org/10.1016/S0092-8674(04)00045- 5
30. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-33; PMID:19167326; http://dx.doi.org/10.1016/j. cell.2009.01.002
31. Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med 2009; 60:167-79; PMID:19630570; http://dx.doi.org/10.1146/annurev.med.59.053006.104707
32. Grillari J, Grillari-Voglauer R. Novel modulators of senescence, aging, and longevity: Small non-coding RNAs enter the stage. Exp Gerontol 2010; 45:302-11; PMID:20080172; http://dx.doi.org/10.1016/j. exger.2010.01.007
33. Lafferty-Whyte K, Cairney CJ, Jamieson NB, Oien KA, Keith WN. Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms. Biochim Biophys Acta 2009; 1792:341-52; PMID:19419692; http://dx.doi.org/10.1016/j.bbadis.2009.02.003
34. O'Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol 2012; 30:295-312; PMID:22224773; http://dx.doi.org/10.1146/annurev-immunol-020711-075013
35. Jamaluddin MS, Weakley SM, Zhang L, Kougias P, Lin PH, Yao Q, Chen C. miRNAs: roles and clinical applications in vascular disease. Expert Rev Mol Diagn 2011; 11:79-89; PMID:21171923; http://dx.doi.org/10.1586/erm.10.103
36. Santos-Reboucas CB, Pimentel MM. MicroRNAs: macro challenges on understanding human biological functions and neurological diseases. Curr Mol Med 2010; 10:692-704; PMID:20937025; http://dx.doi. org/10.2174/156652410793384169
37. Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S, Calin GA, Mukherjee P. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res 2009; 69:9090-5; PMID:19903841; http://dx.doi.org/10.1158/0008-5472. CAN-09-2552
38. He X, Dong Y, Wu CW, Zhao Z, Ng SS, Chan FK, Sung JJ, Yu J. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene. Mol Med 2012; 18:1491-8; PMID:23255074
39. Brabletz S, Bajdak K, Meidhof S, Burk U, Niedermann G, Firat E, Wellner U, Dimmler A, Faller G, Schubert J, et al. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J 2011; 30:770-82; PMID:21224848; http://dx.doi.org/10.1038/emboj.2010.349
40. Brabletz S, Brabletz T. The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer? EMBO Rep 2010; 11:670-7; PMID:20706219; http://dx.doi.org/10.1038/embor.2010.117
41. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10:593-601; PMID:18376396; http://dx.doi.org/10.1038/ncb1722 (Pubitemid 351627379)
42. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995; 92:9363-7; PMID:7568133; http://dx.doi.org/10.1073/pnas.92.20.9363
43. Guo WJ, Datta S, Band V, Dimri GP. Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins. Mol Biol Cell 2007; 18:536-46; PMID:17151361; http://dx.doi.org/10.1091/mbc. E06-05-0447 (Pubitemid 46213222)
44. Li SK, Smith DK, Leung WY, Cheung AM, Lam EW, Dimri GP, Yao KM. FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression. J Biol Chem 2008; 283:16545-53; PMID:18408007; http://dx.doi.org/10.1074/jbc. M709604200
45. Park SM, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008; 22:894-907; PMID:18381893; http://dx.doi.org/10.1101/ gad.1640608 (Pubitemid 351482843)
46. Castilla MA, Diaz-Martin J, Sarrio D, Romero-Perez L, Lopez-Garcia MA, Vieites B, Biscuola M, Ramiro-Fuentes S, Isacke CM, Palacios J. MicroRNA-200 family modulation in distinct breast cancer phenotypes. PLoS One 2012; 7:e47709; PMID:23112837; http://dx.doi.org/10.1371/journal.pone.0047709
47. Neves R, Scheel C, Weinhold S, Honisch E, Iwaniuk KM, Trompeter HI, Niederacher D, Wernet P, Santourlidis S, Uhrberg M. Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells. BMC Res Notes 2010; 3:219; PMID:20682048; http://dx.doi. org/10.1186/1756-0500-3-219
48. Chen L, Li Y, Fu Y, Peng J, Mo MH, Stamatakos M, Teal CB, Brem RF, Stojadinovic A, Grinkemeyer M, et al. Role of deregulated microRNAs in breast cancer progression using FFPE tissue. PLoS One 2013; 8:e54213; PMID:23372687; http://dx.doi. org/10.1371/journal.pone.0054213
49. Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, Mariani O, Nicolas A, Meyniel JP, Cottu P, Sastre-Garau X, et al. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med 2011; 17:1627-35; PMID:22101765; http://dx.doi.org/10.1038/nm.2512
50. Dimri GP. What has senescence got to do with cancer? Cancer Cell 2005; 7:505-12; PMID:15950900; http://dx.doi.org/10.1016/j.ccr.2005.05.025 (Pubitemid 40799244)
51. Magenta A, Cencioni C, Fasanaro P, Zaccagnini G, Greco S, Sarra-Ferraris G, Antonini A, Martelli F, Capogrossi MC. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ 2011; 18:1628-39; PMID:21527937; http://dx.doi. org/10.1038/cdd.2011.42
52. Cao Q, Mani RS, Ateeq B, Dhanasekaran SM, Asangani IA, Prensner JR, Kim JH, Brenner JC, Jing X, Cao X, et al. Coordinated regulation of polycomb group complexes through microRNAs in cancer. Cancer Cell 2011; 20:187-99; PMID:21840484; http://dx.doi.org/10.1016/j.ccr.2011.06.016
53. Ellwanger DC, Buttner FA, Mewes HW, Stumpflen V. The sufficient minimal set of miRNA seed types. Bioinformatics 2011; 27:1346-50; PMID:21441577; http://dx.doi.org/10.1093/bioinformatics/btr149
54. Lal A, Navarro F, Maher CA, Maliszewski LE, Yan N, O'Day E, Chowdhury D, Dykxhoorn DM, Tsai P, Hofmann O, et al. miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol Cell 2009; 35:610-25; PMID:19748357; http://dx.doi.org/10.1016/j. molcel.2009.08.020
55. Dimri GP, Itahana K, Acosta M, Campisi J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol Cell Biol 2000; 20:273-85; PMID:10594030; http://dx.doi.org/10. 1128/MCB.20.1.273-285.2000 (Pubitemid 30002569)
56. Sahasrabuddhe AA, Dimri M, Bommi PV, Dimri GP. βTrCP regulates BMI1 protein turnover via ubiquitination and degradation. Cell Cycle 2011; 10:1322-30; PMID:21430439; http://dx.doi.org/10.4161/cc.10.8.15372
57. Itahana K, Itahana Y, Dimri GP. Colorimetric detection of senescence-associated β galactosidase. Methods Mol Biol 2013; 965:143-56; PMID:23296655; http://dx.doi.org/10.1007/978-1-62703-239-1-8
58. Dimri M, Naramura M, Duan L, Chen J, Ortega-Cava C, Chen G, Goswami R, Fernandes N, Gao Q, Dimri GP, et al. Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior. Cancer Res 2007; 67:4164-72; PMID:17483327; http://dx.doi.org/10.1158/0008-5472.CAN-06-2580 (Pubitemid 46815062)
59. Nelson G, von Zglinicki T. Monitoring DNA damage during cell senescence. Methods Mol Biol 2013; 965:197-213; PMID:23296660; http://dx.doi. org/10.1007/978-1-62703-239-1-13